EarningsInspire Medical Systems, Inc. reported Q2 revenue of $195.9M, ahead of estimates from both the analyst and the Street.
Product ApprovalPositive recent developments include the FDA approval and upcoming limited release of the next-gen Inspire V system, which may reduce average OR times and free up additional capacity for surgeons.
Share Repurchase ProgramINSP announced a $150M share repurchase program, signaling management's continued confidence in their underlying business.